supp.fit

Feverfew: study protocols

5 study groups say how much Feverfew participants took a day. These are the doses the studies gave. They are not a recommendation.

Feverfew: what the research found →

Dose per serving from products

34 products in our catalogue print how much Feverfew a serving holds.

Most common: 250 mg to 500 mg, 38% of 34 products.

Dose per servingProducts
2.5 mg to 5 mg
3
5 mg to 10 mg
0
10 mg to 25 mg
1
25 mg to 50 mg
2
50 mg to 100 mg
4
100 mg to 250 mg
10
250 mg to 500 mg
13
over 500 mg
1

Dose per serving from research

5 study groups in 3 studies say how much Feverfew participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg and 50 mg to 100 mg, 40% of 5 study groups each.

Daily doseStudy groups
5 mg to 10 mg
1
10 mg to 25 mg
2
25 mg to 50 mg
0
50 mg to 100 mg
2

Commonly used together

1 of 5 study groups took Feverfew with something else, but nothing that 3 or more different studies gave.

5 study groups

Study
Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study
2005 · MIG-99 group · People with migraine according to International Headache Society criteria; age and sex not specified
18.8 mg16 weeks89
The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study
2002 · 2.08 mg MIG-99 group · Patients with migraine with or without aura, according to International Headache Society criteria
6.24 mg12 weeks—
The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study
2002 · 6.25 mg MIG-99 group · Patients with migraine with or without aura, according to International Headache Society criteria
18.8 mg12 weeks—
The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study
2002 · 18.75 mg MIG-99 group · Patients with migraine with or without aura, according to International Headache Society criteria
56.3 mg12 weeks—
A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
2004 · active combination · Patients with migraine; age and sex not reported
100 mg90 days—